Galvus
Galvus (vildagliptin) is an oral medicine that is used to treat people with type 2 diabetes. This medicine is used to control blood sugar levels, often together with another type of medicine to lower glucose levels in the blood, such as sulfonylureas and metformin. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, leading to an increase in post-prandial and fasting endogenous levels of incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).
the items you wish
to order
by our qualified
prescriber
to your door step
Please use the options provided to make your final selection.

It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.
Customer Service Team
Confidentiality & Authenticity Assured
- Fully Regulated UK Pharmacy
- Authentic UK sourced medicines only.
- Trading for more than 10 years.
- Information Governance lead ensures all data is confidential
Need Help With Your Questionnaire?
Our customer service team is on hand Monday-Friday to help you with your queries.
Please call us on 08009788956 or
email us at: headoffice@pharmacyplanet.com
Select your preferred options and see the best price
| Pack | Price (£) | ||
|---|---|---|---|
| - | 50mg | 56 Tablets | 75.00 |
| - | 50mg | 112 Tablets | 144.00 |
| - | 50mg | 168 Tablets | 195.00 |
It looks like you missed filling in questions from the last consultation.Click Here to submit your response.
No subscriptions or hidden fees
Secure checkout

UK Regulated online pharmacy
Trusted by over 250,000+ happy customers
Galvus Tablets for Type 2 Diabetes Blood Sugar Management
Living with type 2 diabetes often means learning how your body responds to food, routine, and medication. When diet and exercise alone are not enough, Galvus tablets can offer steady, reliable support.
Galvus contains vildagliptin, a DPP-4 inhibitor used as part of modern oral diabetes tablets for adults with type 2 diabetes. It works alongside your body's natural systems to improve glucose control without overstimulating insulin when it isn't needed. For many people, Galvus becomes part of a balanced diabetes care plan, not a dramatic change, but a steady improvement.
What Is Galvus? How Does It Work?
Galvus belongs to a group of medicines called DPP-4 inhibitors. After you eat, your body releases hormones (called incretins) that signal the pancreas to release insulin. In type 2 diabetes, this system does not work as effectively as it should.
Vildagliptin works by blocking the DPP-4 enzyme, protecting incretin hormones from breaking down too quickly, increasing insulin release only when blood sugar is high, and reducing excess glucose production in the liver. Importantly, Galvus does not force insulin release when blood sugar is low. This makes it different from some other sugar control pills.
When Is Galvus Prescribed?
Galvus is usually prescribed when metformin alone does not provide adequate blood sugar control or when metformin is not suitable. Galvus is used in adults with type 2 diabetes as monotherapy when metformin is not suitable or tolerated, in combination with other diabetic treatments such as metformin, and alongside sulphonylureas or insulin if additional blood sugar management is needed.
It is not used for type 1 diabetes and does not replace insulin where insulin is required.
How to Take Galvus Tablets
Galvus tablets should always be taken exactly as prescribed during your consultation.
Standard Adult Dose:
- 50mg in the morning and 50mg in the evening.
- Total daily dose: 100mg. Do not exceed 100mg per day.
- When combined with a sulphonylurea, the recommended dose may be 50mg once daily.
- In patients with moderate to severe renal impairment, the recommended dose is 50mg once daily. No dose adjustment is required in mild renal impairment.
Galvus can be taken with or without food, swallowed whole with water. If you forget a dose, take it when you remember. Do not take a double dose to make up for a missed tablet.
Although Galvus is generally well tolerated, monitoring is important. Liver function tests should be carried out before and during treatment. Kidney function should be reviewed, especially in moderate or severe renal impairment. HbA1c levels should be checked to assess overall glucose management. Galvus should not be used in patients with significant liver impairment.
Important Safety Information
There are some important risks to be aware of while taking Galvus tablets.
Risk of Pancreatitis: Vildagliptin has been linked to rare cases of acute pancreatitis. Seek urgent medical advice if you experience severe, persistent abdominal pain or pain that may spread to the back. If pancreatitis is confirmed, Galvus should not be restarted.
Liver Monitoring: Rare cases of liver dysfunction have been reported. Stop taking Galvus and seek medical advice if you notice yellowing of the skin or eyes, dark urine, or persistent nausea or fatigue.
Hypoglycaemia Risk: On its own, Galvus has a low risk of causing low blood sugar. However, the risk increases when combined with sulphonylureas or insulin. Dose adjustments of other medicines may be needed.
Possible Side Effects of Galvus Tablets
Like all medicines, Galvus can cause side effects, although not everyone experiences them.
Common Side Effects:
- Headache
- Dizziness
- Nausea
- Mild digestive discomfort
Serious Side Effects:
- Severe abdominal pain (possible pancreatitis)
- Signs of liver problems
- Severe allergic reaction, such as swelling of the face or throat
If any symptoms become severe, persistent, or concerning, contact a healthcare professional without delay.
Why Do People Choose Galvus Tablets?
Galvus is often chosen because it supports blood sugar management without being overly aggressive. People value it because it works with the body's natural incretin system, it does not usually cause weight gain, it carries a lower risk of hypoglycaemia when used alone, and it can be combined with other oral diabetes tablets. For many adults managing type 2 diabetes, Galvus tablets feel like a steady addition rather than a disruptive change.
How to Order Galvus Tablets from Pharmacy Planet
Ordering Galvus tablets from Pharmacy Planet is simple and clinically supervised.
- Complete the online consultation and share details about your type 2 diabetes, current treatment, and recent blood sugar readings.
- A qualified UK prescriber assesses suitability, checks interactions, and confirms the correct dosing plan.
- If approved, your Galvus tablets are dispensed and delivered discreetly to your chosen address.
Living with type 2 diabetes often means learning how your body responds to food, routine, and medication. When diet and exercise alone are not enough, Galvus tablets can offer steady, reliable support.
Galvus contains vildagliptin, a DPP-4 inhibitor used as part of modern oral diabetes tablets for adults with type 2 diabetes. It works alongside your body's natural systems to improve glucose control without overstimulating insulin when it isn't needed.
Galvus belongs to a group of medicines called DPP-4 inhibitors. Vildagliptin works by blocking the DPP-4 enzyme, protecting incretin hormones from breaking down too quickly, increasing insulin release only when blood sugar is high, and reducing excess glucose production in the liver.
Importantly, Galvus does not force insulin release when blood sugar is low. This makes it different from some other sugar control pills.
Galvus is usually prescribed when metformin alone does not provide adequate blood sugar control or when metformin is not suitable. It is used as monotherapy when metformin is not suitable or tolerated, in combination with metformin, and alongside sulphonylureas or insulin if additional blood sugar management is needed.
It is not used for type 1 diabetes and does not replace insulin where insulin is required.
Standard adult dose: 50mg in the morning and 50mg in the evening (total 100mg daily). Do not exceed 100mg per day. When combined with a sulphonylurea, the dose may be 50mg once daily. In moderate to severe renal impairment: 50mg once daily.
Take with or without food, swallowed whole with water. If you miss a dose, take it when you remember — do not double dose.
Pancreatitis: Seek urgent help for severe, persistent abdominal pain or pain spreading to the back. Do not restart Galvus if pancreatitis is confirmed.
Liver Monitoring: Stop and seek advice if you notice yellowing of skin/eyes, dark urine, or persistent nausea or fatigue.
Hypoglycaemia: Low risk alone, but increases when combined with sulphonylureas or insulin. Dose adjustments may be needed.
Like all medicines, Galvus can cause side effects, although not everyone experiences them.
Common Side Effects:
- Headache, dizziness, nausea, mild digestive discomfort
Serious Side Effects:
- Severe abdominal pain (possible pancreatitis)
- Signs of liver problems
- Severe allergic reaction such as swelling of the face or throat
Contact a healthcare professional without delay if symptoms become severe or concerning.
Galvus is often chosen because it works with the body's natural incretin system, does not usually cause weight gain, carries a lower risk of hypoglycaemia when used alone, and can be combined with other oral diabetes tablets. For many adults, it feels like a steady addition rather than a disruptive change.
Ordering Galvus tablets from Pharmacy Planet is simple and clinically supervised.
- Complete the online consultation and share details about your type 2 diabetes, current treatment, and recent blood sugar readings.
- A qualified UK prescriber assesses suitability and confirms the correct dosing plan.
- If approved, your Galvus tablets are dispensed and delivered discreetly to your chosen address.
Galvus carries a lower risk of low blood sugar compared to many sulphonylureas. It also does not usually cause weight gain, which makes it suitable for some patients.
Galvus is usually taken as 50mg in the morning and 50mg in the evening to maintain steady DPP-4 inhibition throughout the day and night.
Yes, Galvus lowers HbA1c by improving insulin release when blood sugar is high. Many patients see measurable improvement within 3 to 6 months.
Galvus contains only vildagliptin, while Eucreas contains vildagliptin plus metformin. Galvus may be used alone or combined with other diabetes medications.
Rare cases of raised liver enzymes have been reported. Liver function tests are checked before starting treatment and monitored during the first year.
Yes, Galvus can be prescribed on its own if metformin is not tolerated due to digestive side effects or other contraindications.
Type 2 diabetes is a progressive condition. Over time, additional or alternative medication may be required to maintain blood sugar control. Regular monitoring helps determine if adjustments are needed.
Yes, Galvus generally has a low interaction risk with common blood pressure medicines. Always declare all medications to your prescriber during consultation.
Galvus should be used with caution in patients with moderate to severe heart failure. Suitability should be assessed during consultation.
Caution is required. If you have a history of pancreatitis, suitability should be carefully assessed before starting Galvus.
clinical consultation
Answer a few questions on your health and your fitness goals.
assessment
Our clinicians will review your clinical questionnaire to make sure treatment is right for you.
aboard!
Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical journey.
Start your journey with us
Need Help?

Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.
To get in touch, contact our Customer Service team on 0800 978 8956 or email headoffice@pharmacyplanet.com.
Review By
HARMINDER ‘HARMY’ KAUR
Last Updated On : Mar 13 2026
BSc(hons) Pharmacy
GPhC Number: 2061107
Authored By
GURDEV SEHMI
Last Reviewed On : Mar 23 2026
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925


